Biofrontera AG - ESG Rating & Company Profile powered by AI
This report of Biofrontera AG was prepared by All Street Sevva using proprietary artificial intelligence. This assessment of Biofrontera AG leverages information from across the web and also from available disclosures by Biofrontera AG. Other companies in the scoring industry group for Biofrontera AG are shown.
Biofrontera AG in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.0; made up of an environmental score of 5.3, social score of 4.8 and governance score of 8.0.
6.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 483 | Wakamoto Pharmaceutical Co Ltd | 6.1 | High |
| 483 | aTyr Pharma Inc | 6.1 | High |
| 498 | Biofrontera AG | 6.0 | High |
| 498 | Cann Group Ltd | 6.0 | High |
| 498 | Biosynex SA | 6.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Biofrontera AG have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Biofrontera AG disclose current and historical energy intensity?
Sign up for free to unlockDoes Biofrontera AG report the average age of the workforce?
Sign up for free to unlockDoes Biofrontera AG reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Biofrontera AG disclose its ethnicity pay gap?
Sign up for free to unlockDoes Biofrontera AG disclose cybersecurity risks?
Sign up for free to unlockDoes Biofrontera AG offer flexible work?
Sign up for free to unlockDoes Biofrontera AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Biofrontera AG disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Biofrontera AG conduct supply chain audits?
Sign up for free to unlockDoes Biofrontera AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Biofrontera AG conduct 360 degree staff reviews?
Sign up for free to unlockDoes Biofrontera AG disclose the individual responsible for D&I?
Sign up for free to unlockDoes Biofrontera AG disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Biofrontera AG disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Biofrontera AG disclose water use targets?
Sign up for free to unlockDoes Biofrontera AG have careers partnerships with academic institutions?
Sign up for free to unlockDid Biofrontera AG have a product recall in the last two years?
Sign up for free to unlockDoes Biofrontera AG disclose incidents of discrimination?
Sign up for free to unlockDoes Biofrontera AG allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Biofrontera AG issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Biofrontera AG disclose parental leave metrics?
Sign up for free to unlockDoes Biofrontera AG disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Biofrontera AG disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Biofrontera AG disclose the pay ratio of women to men?
Sign up for free to unlockDoes Biofrontera AG support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Biofrontera AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Biofrontera AG reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Biofrontera AG involved in embryonic stem cell research?
Sign up for free to unlockDoes Biofrontera AG disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Biofrontera AG disclose its waste policy?
Sign up for free to unlockDoes Biofrontera AG report according to TCFD requirements?
Sign up for free to unlockDoes Biofrontera AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Biofrontera AG disclose energy use targets?
Sign up for free to unlockDoes Biofrontera AG disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Biofrontera AG have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Biofrontera AG
These potential risks are based on the size, segment and geographies of the company.
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; Belixos, a modern active cosmetic product for irritated and sensitive skin; and Xepi for the treatment of antibiotic-resistant bacteria. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.